Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    An NIH site-wide banner announces a transition-related terminology update, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T18:58:48.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T19:57:40.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study details with an access-restriction message; the header/footer remain visible while the main content is blocked.
    Difference
    20%
    Check dated 2026-09-22T22:29:37.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows revision v3.7.0, replacing the previous v3.6.6; this marks a new revision of the study listing without altering the core content displayed to users.
    Difference
    0.1%
    Check dated 2026-09-15T20:52:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing v3.6.5. This indicates the page was updated to a newer site release.
    Difference
    0.1%
    Check dated 2026-09-01T20:55:48.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    No additions or deletions were provided for this page, so there are no changes to interpret in context.
    Difference
    0.1%
    Check dated 2026-08-18T20:49:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.